Might Coronary Flow Influence Transcatheter Heart Valve Neo-Sinus Thrombosis?
نویسندگان
چکیده
منابع مشابه
Very late transcatheter heart valve thrombosis
We describe a case of very late transcatheter heart valve (THV) thrombosis of a first-generation SAPIEN prosthesis (Edwards Lifesciences, Irvine, CA) implanted in a 64-year-old woman with severe symptomatic aortic stenosis. More than 54 mo after implantation, she presented with severe symptomatic prosthesis dysfunction (stenosis) which was successfully treated with oral anticoagulation. To our ...
متن کاملEarly transcatheter heart valve thrombosis detected by multidetector computed tomography
Article history: Received 7 November 2013 Accepted 18 November 2013 Available online 27 November 2013 IA–IC in the online-only Data Supplement). No paravalvular or central leakage was detected and LVEF was unaltered. Echocardiographic image quality did not allow for adequate assessment with regard to the mechanism of THV dysfunction. Contrast-enhanced multidetector computed tomography (MDCT) wa...
متن کاملTreatment and clinical outcomes of transcatheter heart valve thrombosis.
BACKGROUND Valve thrombosis has yet to be fully evaluated after transcatheter aortic valve implantation. This study aimed to report the prevalence, timing, and treatment of transcatheter heart valve (THV) thrombosis. METHODS AND RESULTS THV thrombosis was defined as follows (1) THV dysfunction secondary to thrombosis diagnosed based on response to anticoagulation therapy, imaging modality or ...
متن کاملLate Obstructive Transcatheter Heart Valve Thrombosis Resolved by Rivaroxaban
BACKGROUND Although transcatheter aortic valve replacement (TAVR) has become a worldwide and generally accepted treatment of patients with aortic stenosis at high surgical risk, there is a rising concern and debate about the occurrence of transcatheter heart valve (THV) thrombosis and its impact on TAVR outcome. It seems that the incidence of THV thrombosis is higher than first anticipated, but...
متن کاملBioprostheses "thrombosis" after transcatheter aortic valve replacement.
1. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451–96. 2. Ong SH, Mueller R, Iversen S. Early calcific degeneration of a CoreValve ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation: Cardiovascular Interventions
سال: 2019
ISSN: 1941-7640,1941-7632
DOI: 10.1161/circinterventions.119.008005